[go: up one dir, main page]

CY1114023T1 - Διυποκατεστημενης φθαλαζινης ανταγωνιστες σηματοδοτικης οδου hedgehog - Google Patents

Διυποκατεστημενης φθαλαζινης ανταγωνιστες σηματοδοτικης οδου hedgehog

Info

Publication number
CY1114023T1
CY1114023T1 CY20131100447T CY131100447T CY1114023T1 CY 1114023 T1 CY1114023 T1 CY 1114023T1 CY 20131100447 T CY20131100447 T CY 20131100447T CY 131100447 T CY131100447 T CY 131100447T CY 1114023 T1 CY1114023 T1 CY 1114023T1
Authority
CY
Cyprus
Prior art keywords
signal
competitors
hedgehog
road
road signal
Prior art date
Application number
CY20131100447T
Other languages
English (en)
Inventor
Jolie Anne Bastian
Philip Arthur Hipskind
Daniel Jon Sall
Takako Wilson
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41566219&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1114023(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of CY1114023T1 publication Critical patent/CY1114023T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Η παρούσα εφεύρεση παρέχει νέους ανταγωνιστές της σηματοδοτικής οδού hedgehog 1,4-διυποκατεστημένης φθαλαζίνης χρήσιμους στη θεραπεία καρκίνου.
CY20131100447T 2008-11-03 2013-06-05 Διυποκατεστημενης φθαλαζινης ανταγωνιστες σηματοδοτικης οδου hedgehog CY1114023T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11070308P 2008-11-03 2008-11-03
EP09740613.6A EP2364185B1 (en) 2008-11-03 2009-10-22 Disubstituted phthalazine hedgehog pathway antagonists

Publications (1)

Publication Number Publication Date
CY1114023T1 true CY1114023T1 (el) 2016-07-27

Family

ID=41566219

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100447T CY1114023T1 (el) 2008-11-03 2013-06-05 Διυποκατεστημενης φθαλαζινης ανταγωνιστες σηματοδοτικης οδου hedgehog

Country Status (30)

Country Link
US (1) US8404687B2 (el)
EP (1) EP2364185B1 (el)
JP (1) JP2012507535A (el)
KR (1) KR101335746B1 (el)
CN (1) CN102202737B (el)
AU (1) AU2009320251C1 (el)
BR (1) BRPI0921437A2 (el)
CA (1) CA2742539C (el)
CL (1) CL2011000979A1 (el)
CO (1) CO6382123A2 (el)
CR (1) CR20110202A (el)
CY (1) CY1114023T1 (el)
DK (1) DK2364185T3 (el)
EA (1) EA018931B1 (el)
EC (1) ECSP11011021A (el)
ES (1) ES2418479T3 (el)
HK (1) HK1159010A1 (el)
HR (1) HRP20130527T1 (el)
IL (1) IL211841A0 (el)
MA (1) MA32726B1 (el)
MX (1) MX2011004683A (el)
NZ (1) NZ591945A (el)
PE (1) PE20110433A1 (el)
PL (1) PL2364185T3 (el)
PT (1) PT2364185E (el)
SI (1) SI2364185T1 (el)
TN (1) TN2011000166A1 (el)
UA (1) UA102115C2 (el)
WO (1) WO2010062507A1 (el)
ZA (1) ZA201102448B (el)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2137162B1 (en) * 2007-03-15 2018-08-01 Novartis AG Organic compounds and their uses
NZ588001A (en) 2008-04-29 2012-06-29 Lilly Co Eli Disubstituted phthalazine hedgehog pathway antagonists
US20100041663A1 (en) 2008-07-18 2010-02-18 Novartis Ag Organic Compounds as Smo Inhibitors
WO2010056620A1 (en) 2008-11-17 2010-05-20 Eli Lilly And Company Tetrasubstituted pyridazines hedgehog pathway antagonists
PL2358698T3 (pl) 2008-11-17 2013-01-31 Lilly Co Eli Czteropodstawione pirydazyny jako antagoniści szlaku HEDGEHOG
AR077014A1 (es) 2009-06-19 2011-07-27 Lilly Co Eli Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer
WO2015073691A1 (en) 2013-11-14 2015-05-21 The Board Of Trustees Of The Leland Stanford Junior University Methods for treating cancer by activation of bmp signaling
CN105985321B (zh) * 2015-02-11 2018-10-26 复旦大学 吡唑酞嗪化合物及其制备方法和用途
CN105985320B (zh) * 2015-02-11 2018-10-26 复旦大学 苄基酞嗪化合物及其制备方法和用途
CN105985319B (zh) * 2015-02-11 2019-02-26 复旦大学 芳基酞嗪化合物及其制备方法和用途
KR20230107568A (ko) 2020-10-13 2023-07-17 엔데버 바이오메디신스, 인크. 섬유증 치료 방법
AR130548A1 (es) * 2022-09-23 2024-12-18 Merck Sharp & Dohme Llc Derivados de ftalazina útiles como inhibidores de la proteína receptora 3 similar a nod

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1293565A (en) 1969-05-03 1972-10-18 Aspro Nicholas Ltd Aminophthalazines and pharmaceutical compositions thereof
KR100443893B1 (ko) 1996-01-15 2004-10-15 얀센 파마슈티카 엔.브이. 혈관형성억제제피리다진아민
CN1169795C (zh) * 1996-10-01 2004-10-06 协和发酵工业株式会社 环胺取代的含氮杂环化合物及其组合物
US6432970B2 (en) 1998-04-09 2002-08-13 Johns Hopkins University School Of Medicine Inhibitors of hedgehog signaling pathways, compositions and uses related thereto
AU768130B2 (en) 1998-04-09 2003-12-04 Johns Hopkins University School Of Medicine, The Use of steroidal alkaloid derivatives as inhibitors of hedgehog signaling pathways
AU780358B2 (en) 1999-06-08 2005-03-17 Lorantis Limited Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
US7655674B2 (en) 2002-04-22 2010-02-02 The Johns Hopkins University Modulators of hedgehog signaling pathways, compositions and uses related thereto
WO2004020599A2 (en) 2002-08-29 2004-03-11 Curis, Inc. Hedgehog antagonists, methods and uses related thereto
US8067608B2 (en) * 2003-09-29 2011-11-29 The Johns Hopkins University Hedgehog pathway antagonists
WO2005080378A1 (ja) 2004-02-24 2005-09-01 Mitsubishi Pharma Corporation 縮合ピリダジン誘導体
EP1745039A4 (en) 2004-05-08 2009-07-22 Neurogen Corp 3-ARYL-5,6-DISUBSTITUTED PYRIDAZINES
KR20180122750A (ko) * 2004-09-02 2018-11-13 제넨테크, 인크. 헤지호그 신호전달에 대한 피리딜 억제제
EP1900731A1 (de) 2006-09-07 2008-03-19 Bayer Schering Pharma Aktiengesellschaft N-(1-Phthalazin-1-yl-piperidin-4-yl)-amide als EP2-Rezeptor Modulatoren
EP2137162B1 (en) * 2007-03-15 2018-08-01 Novartis AG Organic compounds and their uses
AU2008269128B2 (en) * 2007-06-25 2012-08-02 Amgen Inc. Phthalazine compounds, compositions and methods of use
ES2392157T3 (es) 2007-09-07 2012-12-05 Amgen Inc. Piridazinas anilladas para el tratamiento de tumores dirigidos por señalización Hedgehog inapropiada
NZ588001A (en) 2008-04-29 2012-06-29 Lilly Co Eli Disubstituted phthalazine hedgehog pathway antagonists
US20100041663A1 (en) 2008-07-18 2010-02-18 Novartis Ag Organic Compounds as Smo Inhibitors
WO2010056620A1 (en) 2008-11-17 2010-05-20 Eli Lilly And Company Tetrasubstituted pyridazines hedgehog pathway antagonists
PL2358698T3 (pl) 2008-11-17 2013-01-31 Lilly Co Eli Czteropodstawione pirydazyny jako antagoniści szlaku HEDGEHOG
AR077014A1 (es) 2009-06-19 2011-07-27 Lilly Co Eli Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer

Also Published As

Publication number Publication date
CA2742539A1 (en) 2010-06-03
TN2011000166A1 (en) 2012-12-17
WO2010062507A1 (en) 2010-06-03
SI2364185T1 (sl) 2013-07-31
CN102202737A (zh) 2011-09-28
KR101335746B1 (ko) 2013-12-12
MA32726B1 (fr) 2011-10-02
CN102202737B (zh) 2014-03-26
EP2364185B1 (en) 2013-05-22
PE20110433A1 (es) 2011-07-09
CL2011000979A1 (es) 2011-10-07
PT2364185E (pt) 2013-07-24
US8404687B2 (en) 2013-03-26
DK2364185T3 (da) 2013-06-03
UA102115C2 (ru) 2013-06-10
EP2364185A1 (en) 2011-09-14
ECSP11011021A (es) 2011-06-30
AU2009320251B2 (en) 2013-01-24
AU2009320251A1 (en) 2010-06-03
MX2011004683A (es) 2011-06-20
IL211841A0 (en) 2011-06-30
CA2742539C (en) 2014-05-06
EA201170640A1 (ru) 2011-12-30
HRP20130527T1 (en) 2013-07-31
ZA201102448B (en) 2012-09-26
ES2418479T3 (es) 2013-08-14
US20110190304A1 (en) 2011-08-04
KR20110066212A (ko) 2011-06-16
PL2364185T3 (pl) 2013-10-31
AU2009320251C1 (en) 2013-08-15
CR20110202A (es) 2011-06-09
CO6382123A2 (es) 2012-02-15
EA018931B1 (ru) 2013-11-29
HK1159010A1 (en) 2012-07-27
NZ591945A (en) 2012-10-26
BRPI0921437A2 (pt) 2018-10-30
JP2012507535A (ja) 2012-03-29

Similar Documents

Publication Publication Date Title
CY1114023T1 (el) Διυποκατεστημενης φθαλαζινης ανταγωνιστες σηματοδοτικης οδου hedgehog
EA201270049A1 (ru) Дизамещенные фталазиновые антагонисты пути hedgehog
CY1121327T1 (el) Τροποποιημενα αντισωματα anti-il-23p19
EA201071248A1 (ru) Дизамещенные фталазиновые антагонисты пути hedgehog
EA200970737A1 (ru) Оксабициклогептаны и оксабициклогептены, их получение и применение
EA201171367A1 (ru) Винилиндазолильные соединения
EA201270619A1 (ru) Применение бетанехола для лечения ксеростомии
EA201000784A1 (ru) Антагонисты пути hedgehog и их терапевтические применения
EA201300242A1 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
ATE469895T1 (de) Cgrp-rezeptorantagonisten
MA32161B1 (fr) Formes de rifaximine et utilisations de celles-ci
MY160736A (en) Bivalent, bispecific antibodies
EA200971068A1 (ru) Триазолиламинопиримидиновые соединения
BRPI0814772A2 (pt) Indazóis substituídos por 5-piridinona
MX2010006206A (es) Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
EA201170700A1 (ru) Тетразамещенные пиридазины в качестве антагонистов пути hedgehog
MA32321B1 (fr) Pregn-4-en-21, 17 carbolactones substitués sur le noyau c, et préparations pharmaceutiques contenant ces derniers
EA200971067A1 (ru) Триазолиламинопиримидиновые соединения
ATE512185T1 (de) Heterobifunktionelle polyethylenglycol-reagenzien
CY1111328T1 (el) Χαρακτηρισμος: αξομαδολη για τη θεραπεια πονου σε αρθριτιδα
NO20091386L (no) Fenyloksyanilinderivater
DK2081944T3 (da) Nye morfin-derivater
ATE499138T1 (de) Implantierbare vorrichtung
CY1114078T1 (el) Ανταγωνιστες διυποκατεστημενης φθαλαζινης του μονοπατιου hedgehog
TN2010000489A1 (en) Disubstituted phthalazine hedgehog pathway antagonists